Innovate Pharmaceuticals banks another $5.5 million

A Raleigh-based pharmaceutical company is continuing its pursuit of fundraising, bringing another $5.5 million into its account this week. On March 15, Innovate Biopharmaceuticals (Nasdaq: INNT) announced a $5.5 million fundraising round that started on March 8, by way of a securities purchase agreement with Atlas Science – a Utah company. Under the terms of the deal, Atlas may elect to convert all or a portion of the note at any time and from time to time into the Company’s common stock…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news